Neomente is a brand dedicated to improving the quality of life for the over 800 million people worldwide who struggle with mental health issues. Our mission is to help them recover as quickly as possible. At Neomente, we have developed a Clinical Decision Support System (SSDC) that combines various biomarkers to provide healthcare professionals with a tool to choose the most appropriate medication for their patients.

This increases the likelihood of a positive response and reduces the risk of side effects. Our SSDC allows professionals to make personalized clinical decisions based on neurosciences and supported by technology. The SSDC analyzes how your genes and other blood parameters can affect the effectiveness of medication prescribed for depression, ADHD, schizophrenia, and epilepsy.

The test results provide valuable information to your doctor about how you may respond to treatment, helping them select the most suitable options for your unique profile. The result includes biomarkers, pharmacological interactions, genetically predictable adverse reactions, personalized dosages, and explanations of the results to your healthcare professional. The results are securely sent to your psychiatrist or neurologist via email, ensuring proper guidance in modifying your treatment if necessary.

Please note that while the SSDC is an informative tool, it requires a medical order as it is specifically designed for healthcare professionals. If you have not started treatment yet, we can connect you with a professional. For more information or to purchase the SSDC, please contact us at info@neobiomarkers.

com. Neomente also actively participates in research studies, including a double-blind clinical trial in precision medicine for depression, conducted in collaboration with reputable healthcare institutions. The study aims to enroll patients in Buenos Aires who meet the inclusion criteria.

Additionally, Neomente is involved in the development of an ADR Test to detect the risk of adverse cutaneous reactions induced by antiepileptic drugs, in collaboration with the Hospital Favaloro and the Primer Centro Argentino de Inmunogenética (PRICAI) of the Fundación Favaloro. Invest in your mental health today and benefit from our expertise in biomarker analysis, personalized dosages, and continuous clinical support through our user-friendly app. Join us at Neomente and regain control of your mental well-being.

Contact us at info@neomente. com and follow us on social media for more updates